The biology and treatment of Merkel cell carcinoma: current understanding and research priorities

The biology and treatment of Merkel cell carcinoma: current understanding and research prioritiesThe biology and treatment of Merkel cell carcinoma: current understanding and research priorities, Published online: 04 October 2018; doi:10.1038/s41571-018-0103-2Merkel cell carcinoma (MCC) is a rare and aggressive form of nonmelanoma skin cancer. The availability of immune checkpoint inhibition has improved the outcomes of a subset of patients with MCC, although many unmet needs continue to exist. In this Consensus Statement, the authors summarize developments in our understanding of MCC while also providing consensus recommendations for future research.

Source: Nature Clinical Practice Oncology - October 4, 2018 Category: Cancer & Oncology Authors: Paul W. Harms Kelly L. Harms Patrick S. Moore James A. DeCaprio Paul Nghiem Michael K. K. Wong Isaac Brownell Source Type: research